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Abstract
Nearly one million deaths are attributed to malaria every year. Recent reports of multi-drug treatment failure of falciparum
malaria underscore the need to understand the molecular basis of drug resistance. Multiple mutations in the Plasmodium
falciparum chloroquine resistance transporter (pfcrt) are involved in chloroquine resistance, but the evolution of complex
haplotypes is not yet well understood. Using over 4,500 archival human serum specimens collected from 19 Pacific
populations between 1959 and 1979, the period including and just prior to the appearance of chloroquine treatment failure
in the Pacific, we PCR-amplified and sequenced a portion of the pfcrt exon 2 from 771 P. falciparum-infected individuals to
explore the spatial and temporal variation in falciparum malaria prevalence and the evolution of chloroquine resistance. In
the Pacific, the prevalence of P. falciparum varied considerably across ecological zones. On the island of New Guinea, the
decreases in prevalence of P. falciparum in coastal, high-transmission areas over time were contrasted by the increase in
prevalence during the same period in the highlands, where transmission was intermittent. We found 78 unique pfcrt
haplotypes consisting of 34 amino acid substitutions and 28 synonymous mutations. More importantly, two pfcrt mutations
(N75D and K76T) implicated in chloroquine resistance were present in parasites from New Hebrides (now Vanuatu) eight
years before the first report of treatment failure. Our results also revealed unexpectedly high levels of genetic diversity in
pfcrt exon 2 prior to the historical chloroquine resistance selective sweep, particularly in areas where disease burden was
relatively low. In the Pacific, parasite genetic isolation, as well as host acquired immune status and genetic resistance to
malaria, were important contributors to the evolution of chloroquine resistance in P. falciparum.
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Introduction
Malaria caused approximately 243 million clinical cases and
863,000 deaths in 2008 [1]. The development of resistance to
chloroquine (CQ), once the mainstay of malaria treatment
worldwide, has exacerbated malaria morbidity and mortality over
the last few decades, especially in sub-Saharan Africa [2,3]. An
understanding of the evolution of CQ resistance in the malaria
parasite Plasmodium falciparum is crucial to providing important
insights into the mechanisms by which parasites respond to other
aminoquinolines such as amodiaquine, which are currently used as
partner drugs with artesunate in artemisinin-based combination
therapies (ACTs). Such insights are urgently needed, given recent
evidence of diminished efficacies of ACTs in Southeast Asia [4].
CQresistant (CQR) P. falciparum show diminished accumulation of
CQ in the digestive vacuole (DV), and this phenotype is correlated
with amino acid substitutions in the DV membrane transporter, P.
falciparum chloroquine resistance transporter (pfCRT) [5]. In pfCRT,
the lysine to threonine substitution at codon position 76 (K76T) shows
the most consistent correlation with CQ resistance, but as many as
eight other amino acid substitutions are alsoinvolved in distinguishing
CQR from CQ sensitive (CQS) parasites [5,6]. Together with K76T,
substitutions at positions 72, 74, and 75 formcomplex CQR pfcrtexon
2h a p l o t y p e st h a tc o r r e s p o n dt ot he geographical origins of CQ
resistance [6]. However, it is unclear how these CQR pfcrt haplotypes
arose due to the lack of previous genetic characterization of parasites
during the periods of CQ resistance emergence.
Multiple origins of CQ resistance in P. falciparum have been
suggested based on epidemiological data [7] and genetic analyses
[5,6]. CQ treatment failures first appeared simultaneously near the
Thai-Cambodian border and in Colombia in the late 1950s, and
CQR parasites spread from these original foci to neighboring
areas [7]. Characterization of pfcrt haplotypes from laboratory-
adapted P. falciparum clones provided strong support for these two
independent origins of CQ resistance, and the invasion of CQR
parasites from Southeast Asia to Africa [5,6].
In Papua New Guinea (PNG), CQ treatment failure was first
reported in1976,andwasinitiallyassumed toindicatetheexpansion
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30213of CQR P. falciparum from Southeast Asia into the Pacific [7,8].
Examination of pfcrt polymorphisms showed that despite the
geographic proximity to the Southeast Asian focus of resistance,
CQR parasites from PNG harbored a pfcrt exon 2 haplotype similar
to one from South America [9]. Since these pfcrt substitutions were
associated with a different genetic background [6,10], it was argued
that PNG represented another independent focus of CQ resistance
[9].
In other malarious regions of the Pacific, the evolution of CQ
resistance in P. falciparum might have been more complex. Nagesha
et al. [11] identified four pfcrt haplotypes associated with CQ
resistance in field isolates from Indonesian Papua (West New
Guinea or WNG). These haplotypes were representative of both
the Southeast Asian/African (codon 72–76: CVIET) and the
PNG/South American (codon 72–76: SVMNT) CQR haplotypes,
and a third composite (codon 72–76: SVIET) haplotype. This
region of the Pacific is also characterized by very diverse ecologies
which affect parasite population dynamics that in turn play a
crucial role in the evolution of CQR parasites and their dispersals
[12]. In this regard, it is important to include parasites from
multiple locales and examine their interactions at a population
level over time.
Archival biological specimens have been shown to be useful in
studying past evolutionary events such as CQ resistance in P.
falciparum [13,14]. We reasoned that blood samples collected prior
to (and slightly after) the mid-1970s from populations residing in
the malarious Pacific might contain DNA from P. falciparum that
was under increasing CQ selection. Genotyping of pfcrt might
therefore provide important insights into the evolution of the
complex CQR haplotypes. Additionally, by including samples
from multiple locations collected at various time periods, we
sought to examine the spatial and temporal dynamics of the
evolution and spread of CQR P. falciparum across the diverse
environments in the Pacific [12]. Results from our study indicated
that pfcrt exon 2 was highly diverse prior to the CQ selective
sweep, and suggested that CQ resistance in the Pacific evolved in
situ and arose first in low transmission areas, where host
populations had minimal genetic resistance and acquired immu-
nity against malaria infections.
Results
Overall, 771 of 4598 (16.8%) specimens from 19 populations
were positive for P. falciparum (Figure 1, Table S1), as determined
by successful PCR amplification and DNA sequencing of a 195-bp
segment of pfcrt exon 2 corresponding to codon positions 36 to 99.
Rates of P. falciparum infection ranged from 0% in the Papua New
Guinea (PNG) eastern highlands sample of BAR62 and the West
New Guinea (WNG) coastal sample of MRK61 to 55.4% in the
WNG coastal sample of SWC60 (Figure 1, Table S1). When
analyzed by ecological zones, coastal populations from both WNG
and PNG showed the highest average rates of P. falciparum
infection at 26.9% and 20.3%, respectively, followed by those
from Island Melanesia at 17.4% and PNG Papuan Plateau at
13.6%, with those from the PNG eastern highlands showing the
lowest rate at 3.14% (Table S1). Our results from PNG were
consistent with the observation that malaria prevalence decreases
with increasing altitude [15].
For three of the five ecological zones, longitudinal samples
allowed for crude estimates of temporal variation in P. falciparum
Figure 1. Approximate locations of populations. Populations are denoted by their sample codes (Table S1) and assigned to one of five
ecological zones as indicated by colors as followed: WNG coast (purple), PNG coasts (green), PNG Papuan Plateau (blue), PNG eastern highlands (red),
and Island Melanesia (orange). Samples collected from the same locations in different years (e.g. SWC60, SWC62, and SWC69) did not represent
repeated samplings from the same populations.
doi:10.1371/journal.pone.0030213.g001
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from 1960 to 1969, while on the PNG coasts, there was a steady
decrease in prevalence from 1960 to 1979. In contrast, P. falciparum
prevalence increased slightly over the same period in the PNG
eastern highlands (Figure 2).
Approximately 8.95% (69/771) of P. falciparum-positive specimens
showed two distinct pfcrt exon 2 genotypes, yielding a total of 840
sequences (GenBank accession numbers HM019533–HM020128,
HM020130–HM020332, and HM202334–HM020374). Samples
from the PNG eastern highlands and Island Melanesia showed the
highest frequencies of individuals with multiple infections (Table S1).
Seventy eight unique pfcrt haplotypes were identified, of which the
wildtype pfcrt sequence accounted for 83.8% (704/840) of sequences.
We calculated pfcrt haplotye diversities to compare the amounts
of genetic variation among populations and ecological zones.
Haplotype diversity indices range between 0 and 1. A measure of 0
indicates that all haplotypes within a population or ecological zone
are identical to one another, whereas a measure of 1 indicates that
all haplotypes within a population or ecological zone are unique.
When analyzed by individual populations, pfcrt haplotype diversity
ranged from 0 in EHP60, WSP65, and ONB69, to 0.722 in
EHP79 (Table S1). When grouped into ecological zones, popula-
tions from the PNG eastern highlands and Island Melanesia had
higher haplotype diversities than those from the other ecological
zones, although the difference was not statistically significant
(ANOVA; p=0.106) (Table S1). Pfcrt haplotype diversities did not
vary substantially over time along the WNG coast, but in both
PNG coasts and eastern highlands the levels of diversity showed
substantial fluctuations, with an appreciable increase over time in
the PNG eastern highlands (Figure 2).
Among the 77 mutant pfcrt haplotypes, non-synonymous
substitutions were more abundant (34 vs. 28) and occurred more
frequently (94 vs. 75) than synonymous substitutions. During the
two early periods (1959–61 and 1962–65), no differences were
found in the distribution of mutant pfcrt haplotypes among
populations (Figures 3, 4). Between 1969 and 1972, significantly
more (p,0.001) mutant pfcrt haplotypes were found in populations
from Island Melanesia than those from the PNG Papuan Plateau
and the WNG coast (Figure 5). In 1979, the PNG eastern
highlands have significantly more (p=0.018) mutant pfcrt haplo-
types than the PNG coast (Figure 6). Fifty two (67.5%) mutant pfcrt
haplotypes contained at least one non-synonymous substitution.
Most mutations observed were either private or present at very low
frequencies. Only five mutant haplotypes (6, 14, 24, 26, and 39)
were found in five or more individuals (Figures 3–6). Three amino
acid substitutions previously implicated in CQ resistance were
detected in our samples. In NNH72, the N75D (codon 72–76:
CVMDK) and the K76T (codon 72–76: CVMNT) substitutions
were found individually in two specimens (Figure 5), while the
K76N (codon 72–76: CVMNN) substitution was found in one
specimen from EHP79 (Figure 6).
The relationship among pfcrt exon 2 haplotypes from each time
period is shown by a median-joining network diagram (Figures 3–
6). The wildtype pfcrt haplotype was shared by all populations.
Nine mutant pfcrt haplotypes (3, 6, 10, 11, 12, 14, 24, 25, and 26)
were found in samples from at least two time periods (Figures 3–6).
Figure 2. Temporal variation in P. falciparum infection rates (bar) and pfcrt haplotype diversities (line). Ecological zones are indicated by
colors as followed: PNG eastern highlands (red), WNG coast (purple), and PNG coasts (green).
doi:10.1371/journal.pone.0030213.g002
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synonymous substitutions while the remaining five had only
synonymous mutations (Figures 3–6). Overall, 83.3% (65/78) of
haplotypes were population specific. Of the 12 mutant pfcrt
haplotypes shared between two or more populations, 10 were
shared between populations from different ecological zones.
We also calculated pairwise FST genetic distances to infer gene
flow among parasite populations across ecological zones and
persistence of parasite populations within ecological zones over
time. Gene flow among populations from the same time period, as
defined by non-statistically significant (p.0.05) pairwise FST values,
is illustrated in Figure 7. During the two early periods (1959–61 and
1962–65), parasite populations from different ecological zones were
not significantly differentiated from one another (Figures 7A and
7B). Between 1969 and 1972, parasite populations in Island
Melanesia were significantly differentiated from those in the PNG
Papuan Plateau and the WNG coast (Figure 7C). In 1979, parasites
in the PNG eastern highlands were significantly differentiated from
those in the PNG coast (Figure 7D). No statistically significant
(p,0.05) FST values were found among temporally distinct samples
within the same ecological region, suggesting that parasite
populations within a particular region generally persisted through
time. The spatial and temporal patterns of gene flow as inferred
from pairwise FST distances suggested that P. falciparum CQ
resistance in the Pacific likely arose locally and evolved in situ.
Discussion
Malaria endemicity in the Pacific is inversely correlated with
latitude and altitude [15,16]. In PNG, malaria transmission is most
intense in coastal lowlands where both temperature and rainfall
remain high throughout the year, whereas in the highlands,
transmission is epidemic and coincides with the conclusion of the
rainy season [15]. In Vanuatu, a Y-shaped archipelago that
extends along the north-south axis in the southern hemisphere,
malaria transmission in the northern islands is in general more
intense than in the southern islands, with the southernmost island
of Aneityum being free of malaria since 1991 [16,17]. In our
archival samples, the pattern of P. falciparum prevalences as
determined by our PCR and sequencing assays was consistent with
that obtained by current malariometric surveys. Since all four
commonly recognized human malaria species are present in the
southwest Pacific [15], and our molecular techniques specifically
targeted template DNA from P. falciparum, it is likely that the rates
of malaria infections in these archival samples were higher than
reported here, especially in the PNG highlands, where unstable
malaria transmission has historically favored the predominance of
P. vivax [18,19].
The prevalence of P. falciparum infections in coastal and
highland samples of New Guinea showed opposite longitudinal
trends, which are consistent with changing social factors of the
Figure 3. Median-joining network of pfcrt haplotypes (A) and alignment of translated sequences (B) from 1959–61. In the network
diagram, each unique pfcrt haplotype is represented by a node, and the size of each node is proportional to the frequency of the haplotype.
Substitutions are represented by branches, with the branch length proportional to the number of substitutions. Non-synonymous substitutions are
represented by branches in bold. Pfcrt haplotypes that appeared in more than one time period are noted by their haplotype numbers. In the amino
acid sequence alignment, the shaded region represents transmembrane domain 1. Synonymous substitutions are represented by dashes (-) and
synonymous substitutions by asterisks (*). Populations are denoted by their sample codes (Table S1).
doi:10.1371/journal.pone.0030213.g003
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decreasing prevalence over time coincided with the initiation of
malaria eradication programs. Malaria control measures began in
both PNG and WNG in 1952, consisting of residual insecticide
spraying, introduction of Gambusia spp. to swampy areas, and in
some places mass drug administration of CQ and/or pyrimeth-
amine [20]. Although complete eradication proved elusive,
notable reduction in malaria prevalence was accomplished in
many lowland areas despite technical and logistical difficulties [20–
23]. In contrast to the overall decrease in P. falciparum prevalence
in the lowlands, we observed a slight increase in infection rate in
the PNG eastern highlands over time. Radford et al. [24] argued
that social factors were important in changing malaria epidemi-
ology in the highlands. Increased contact and the opening of the
Highland Highways facilitated the movement of people and
malaria parasites from the highly malarious coastal areas to the
highlands, while many highlanders recruited as wage laborers in
lowland plantations served as parasite reservoirs when they
returned to the highlands. Establishment of plantations and
adoption of western-style housing in the highlands also created
additional mosquito breeding sites that led to increased malaria
transmission [19,24]. The increase in P. falciparum prevalence in
our PNG eastern highland samples might also represent a gradual
shift in species predominance from P. vivax to P. falciparum,a s
recently noted by Mueller et al. [19], although this will require
molecular surveys of P. vivax to confirm.
In the Pacific, CQ treatment failure was first reported in WNG
(Irian Jaya) in 1974 [25] and by 1980 resistance had been
confirmed in all malaria endemic countries in the region [7]. Two
CQ resistance-implicated amino acid substitutions, N75D and
K76T were observed individually in two specimens from NNH72,
resulting in the haplotypes CVMDK and CVMNT, respectively.
The pfcrt K76T substitution has consistently been shown to
correlate with CQ resistance [5,16,26], and the CVMNT
haplotype has previously been described in CQR parasites from
South America [5] and Papua [11]. The N75D substitution was
associated with the K76T substitution in parasites from Cambodia
[27], Thailand and Laos [28], although in the absence of the
diagnostic K76T substitution, it is unclear if this CVMDK-bearing
parasite had an altered response to CQ. The presence of these
substitutions in parasites from northern New Hebrides in 1972
agrees with the long held suspicion that CQ resistance had been
present in New Hebrides many years before it was clinically and
experimentally confirmed in 1980 [29,30].
We also detected the replacement of lysine by asparagine at pfcrt
codon 76 in EHP79. This K76N substitution was previously
experimentally induced when the CQS laboratory clone 106/1,
which already had six of the seven pfcrt mutations found in CQR
parasites from Asia and Africa, was exposed to high levels of CQ
[31]. However, it is unclear whether the 76N bearing parasite we
identified in this study was CQR, since it was associated with a
different pfcrt genetic background. Whereas the mutant 106/1
Figure 4. Median-joining network of pfcrt haplotypes (A) and alignment of translated sequences (B) from 1962–5.
doi:10.1371/journal.pone.0030213.g004
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the CVMNN haplotype. This rare haplotype has been reported
twice in parasite isolates from Indonesia, although in both studies
the in vitro response to CQ was not evaluated [28,32].
Archival biological samples from PNG provide crucial insights
into the evolution and spread of CQR parasites [13,14,28]. Using
samples collected from 12 locations in PNG during the early 1980s,
Mehlotra et al. [13] found a high frequency (97%; 33/34) of the
CQR SVMNT pfcrt haplotype, which was consistent with a nation-
wide epidemiological survey reporting widespread CQ resistance
conducted during that period [33]. In contrast, the CQS CVMNK
haplotype predominated (97%; 34/35) in our PNG samples
collected in 1979 (EHP79 and WSP79), indicating that strong CQ
selection resulted in the nearly complete replacement of CQS
parasites by their resistant counterparts in as few as three years, and
the latter’s persistence to the present [9,34]. It is unclear whether the
CVMNN haplotype observed in our sample represented a
transitional strain that ultimately gave rise to parasites carrying the
more ubiquitous SVMNT haplotype seen today, or was replaced by
invadingparasitescarryingthelatterhaplotype,nonethelessourdata
are consistent with previous interpretation that CQ resistance in the
Pacific evolved in situ [9]. Analyses of additional samples from this
critical period are currently underway and will hopefully shed light
on the relationships among these haplotypes.
Of the 34 amino acid substitutions observed in our samples, 20
are considered to be non-conservative, involving a side-chain
property change in either polarity and/or charge that might affect
the function of the protein. Two such substitutions, I59T and I63T
were observed in 14 and 19 samples respectively. In particular,
mutant pfcrt haplotypes harboring the I63T substitution persisted
through time and later dispersed into multiple regions, suggesting
that these haplotypes may reflect a drug tolerant if not resistant
phenotype (Figures 3–6). Transfections of CQS P. falciparum clones
with I63T and other novel substitutions identified in this study are
currently underway to evaluate their effects on CQ response.
It remains unclear how the historical use of other antimalarials
prior to our earliest samples (1959) might have contributed to the
selection of pfcrt alleles observed in this study. During WWII,
malaria was a major cause of casualties for both the Japanese and
the Allied troops stationed in the Southwest Pacific [35,36].
Quinine and quinacrine, also known as mepacrine or Atabrine,
were used extensively to prevent and treat malaria infections,
especially among Allied soldiers [37]. The mode of action for
quinine is thought to be similar to that of CQ [38], and cross
resistance with CQ has been suggested [39,40], although the
association between quinine resistance in P. falciparum and specific
substitutions in pfcrt has been inconclusive [41]. Quinacrine
resistance was first noted in P. falciparum from the Wewak-Aitape
region along the north coast of New Guinea in 1944 [37]. We did
observe in our earliest sample from the same region (ESP61) a
non-synonymous substitution (F48L) at relatively high frequency
(6.1%; 3/49) (Figure 3), which might reflect previous selection by
Figure 5. Median-joining network of pfcrt haplotypes (A) and alignment of translated sequences (B) from 1969–72. Hypothetical
nodes are indicated by arrows.
doi:10.1371/journal.pone.0030213.g005
Figure 6. Median-joining network of pfcrt haplotypes (A) and alignment of translated sequences (B) from 1979.
doi:10.1371/journal.pone.0030213.g006
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noted that the genetic basis for quinacrine resistance is unknown,
and the use of quinacrine was largely abandoned after WWII in
favor of CQ [42], such that little selective pressure was maintained
during the intervening years between the end of the war and the
collection of our samples.
Four factors may have contributed to the unexpectedly higher
levels of pfcrt exon 2 genetic diversity in parasites from the PNG
eastern highlands and Island Melanesia. First, in Island Melanesia
the high level of parasite genetic diversity might have resulted from
population structure. Samples from NNH72 and SSI72 were
collected from populations on 13 and three different islands,
Figure 7. Gene flow among P. falciparum populations from different ecological zones. Gene flow among parasite populations from (A)
1959–61, (B) 1962–5, (C) 1969–72, and (D) 1979, is represented by solid lines. Gene flow is inferred from pairwise FST distances determined to be non-
statistically significant (p.0.05).
doi:10.1371/journal.pone.0030213.g007
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each archipelago were noted [43], more recently extensive human
contact has been essential for gene flow between parasites on
different islands [44,45]. When subdivided into individual islands,
parasites on some islands were found to be genetically distinct
from those on neighboring islands. For example, parasites from
Gaua in northern New Hebrides were significantly distinct from
those on nearby Mota Lava (FST=0.04155; p=0.03604) and
Vanua Lava (FST=0.01819; p=0.03604). This implies that
isolation and genetic drift on individual islands, although reducing
diversity locally, have increased the genetic diversity of the
archipelago as a whole.
Second, in these areas of relatively low transmission, the use of
antimalarials was often reserved for treatments only [43], such that
intermittent CQ pressure might have selected for a suite of
different non-synonymous substitutions that only slightly altered
the parasites’ response to CQ. In contrast to high transmission
areas where competition among different genetic strains is intense
[46], even in the absence of continuous CQ selection, genetic drift
may have maintained these non-synonymous substitutions in small
parasite populations as suggested by low rates of infection in these
low transmission areas.
Third, host immune status played an important role in the
occurrence of multiple infections. In high transmission areas the
host acquired immunity to malaria is constantly maintained by
recurrent infections, whereas in low transmission areas malaria
infections by multiple genetic strains might be more common since
parasite clearance in semi-immune individuals is less effective [47].
In this study, the frequencies of multiple infections were significantly
correlated with pfcrt haplotype diversities (R
2=0.9361, p=0.007),
suggesting thatlowered host acquiredimmunityinthe PNGEastern
Highlands and Island Melanesia might have contributed to the high
level of parasite genetic diversities in these low transmission areas.
Lastly, differences in host genetics may have affected the degree
to which populations living in different ecological regions were
susceptible to infection by multiple genetic strains of P. falciparum.
Strong selection in the coastal lowland populations of PNG results
in the maintenance of a number of red cell polymorphisms con-
ferring resistance to malaria, including Southeast Asian ovalocytosis
[48–50], alpha-thalassemia [51], beta-thalassemia [52], and Ger-
bich negativity [53]. It is possible that in high transmission areas,
individuals with one or more of these malaria resistant alleles
present a less hospitable environment to parasites, such that only
those that are most adapted, i.e. either wildtype (with no pfcrt
mutations) or fully CQR (with a complete suite of CQR pfcrt
mutations), can survive. Conversely in low transmission areas, host
selection against parasites might be less severe, thus allowing slightly
lessfit parasite strains, i.e. thosewithonlyoneor two pfcrt mutations,
to evolve and persist.
Genetic characterization of P. falciparum in the Pacific from
the period of CQ resistance emergence revealed that prior to
complete CQ selective sweep, pfcrt exon 2 was highly diverse,
highlighted by a number of previously undescribed substitutions
including several implicated in CQ resistance, consistent with in
situ evolution of resistance within the Pacific. In addition to CQ
selection, isolation among parasite populations and reduced
strain competition in small parasite populations, combined with
lowered acquired immunity and genetic resistance to malaria
among hosts in low transmission areas, might have been crucial
to the evolution and initial establishment of CQR P. falciparum in
the Pacific. These data suggest that populations at the peripheries
of malaria endemic areas may be the most crucial to monitor for
parasites evolving tolerance and resistance to currently used
antimalarials.
Materials and Methods
Ethics Statement
This study was submitted to the Human Subjects Research
Review Committee of Binghamton University, where it was
reviewed and determined exempt because no human DNA was
examined (Protocol # 787-08).
Archival Human Serum Collections
Samples used in this study were provided by the Binghamton
University Serum Archive Facility at Binghamton, NY, USA, and
their use in this study was approved by the institutional review
board of Binghamton University. Samples were collected under
the ethical and legal guidelines of the United States National
Institutes of Health and all existing international standards of the
time, and their continued use for biomedical research has recently
been reaffirmed by the Papua New Guinea Medical Research
Advisory Committee (documentation available upon request). A
total of 4598 specimens from 19 Pacific populations sampled
between 1959 and 1979 was included in this study. The locations
of sample collections and brief descriptions are given in figure 1
and table S1, respectively. Samples collected from the same
locations in different years did not represent repeated samplings of
the same populations.
Nucleic Acid Extraction
DNA was extracted from 200 ml of human serum using either
the QIAamp Blood Mini Kit (QIAgen Biosciences, Germantown,
MD) or the automated Maxwell-16 system (Promega, Madison,
WI) according to the respective manufacturers’ instructions.
Eluted DNA was frozen at 220uC until use.
Molecular Analysis
A segment of the pfcrt exon 2 was PCR-amplified in a 12.5 ml
reaction containing 4 ml of DNA, 0.2 mM of dNTP, 2 mM of
MgCl2, 0.5 mM of each primer (CRT76-sense 59-GGTGGAGGT-
TCTTGTCTTGG-39 and CRT76-antisense 59-ATAAAGTTGT-
GAGTTTCGGATG-39) [54], and 0.25 unit of HotStar Taq DNA
polymerase (QIAgen Biosciences, Germantown, MD). The cycling
conditions consisted of 15 minutes at 95uC, 90 seconds at 61uC,
60 seconds at 72uC for 1 cycle; 10 seconds at 95uC, 90 seconds at
61uC, and 2 minutes at 72uC for 50 cycles, and a final extension for
10 minutes at 72uC. PCR amplicons were purified using the
Millipore Manu03050 Filter Plate (Millipore, Billerica, MA), and
were sequenced in both directions using internal primers, CRTD1
59-TGTGCTCATGTGTTTAAACTT-39 and CRTD2 59-CAA-
AACTATAGTTACCAATTTTG-39 [55], with the BigDye Ter-
minator Kit v.3.1 on an ABI 3730xl DNA Analyzer (Applied
Biosystems, Foster City, CA).
Electropherograms were visually checked using Sequencing
Analysis 2.1 (Applied Biosystems, Foster City, CA). Infection by
genetically distinct P. falciparum strains was inferred when
heterologous peaks were present in a single specimen. In cases
where heterologous peaks were observed at more than one
nucleotide position in a single specimen, pfcrt haplotypes were
constructed based on the relative peak heights at each nucleotide
position in question. Assuming that multiple substitutions in a
lineage arose in a stepwise manner, we examined the position of
the constructed halpotypes in the network diagrams (Figures 3–6)
[56]. Only two branches directly stemming from the wildtype pfcrt
haplotype contained hypothetical internal nodes (Figure 5),
indicating that most of these constructed haplotypes were derived
from simpler haplotypes that were also present in our data set.
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Prevalence of P. falciparum infection was determined at two
hierarchical levels. Since malaria endemicity in the Pacific varies
by altitude and latitude [15,16], in addition to comparisons among
all samples, individual samples were assigned to one of five
ecological zones: (1) PNG eastern highlands, (2) WNG coast, (3)
PNG coasts, (4) PNG Papuan Plateau, and (5) Island Melanesia,
consisting of New Hebrides (now Vanuatu) and Solomon Islands
(Figure 1). Samples used in this study were collected over a span of
20 years (1959–79), and were therefore divided into the following
periods, (A) 1959–61, (B) 1962–5, (C) 1969–72, and (D) 1979, to
account for temporal variation and assess the persistence of
genotypes over time.
Pfcrt haplotype diversity was calculated for each population and
each ecological zone using the equation: H=n(12gXi
2)/(n21),
where n is the number of pfcrt sequences, and Xi is the frequency of
the i-th haplotype [57]. Mean pfcrt haplotype diversities among
ecological zones were compared using one-way analysis of
variance (ANOVA). For each time period, G-test for homogeneity
was used to compare the distribution of mutant pfcrt haplotypes
among populations. Median-joining network diagrams were
constructed using the software Network 4.600 to illustrate the
phylogenetic relationships among all pfcrt sequences for each
period [56,58].
To infer gene flow among populations, two sets of pairwise FST
genetic distances were calculated using Arlequin 3.1 [59]. The first
set consisted of comparisons of samples from the same time period
to examine gene flow across ecological zones, while the second
consisted of samples from the same ecological zone but were
collected in different periods to infer replacement (or persistence)
over time. The statistical significance (p,0.05) of the observed
values was evaluated by randomly permuting sequences among
populations approximately 10,000 times to generate a null
distribution against which the observed values were compared.
Supporting Information
Table S1 The approximate geographic locations of these
samples are shown in Figure 1. Samples collected from the same
locations in different years did not represent repeated samplings of
the same population. Ages of donors for the sample EHP79 were
not available.
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